Corcept director reports 5,000-share stock gift
Corcept Therapeutics director James N. Wilson reported a bona fide gift of 5,000 shares of Common Stock on April 6, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics director James N. Wilson reported a bona fide gift of 5,000 shares of Common Stock on April 6, 2026. The transfer was made by the James N. Wilson and Pamela D. Wilson Trust and is classified as a non-market, no‑price gift disposition.
Following the gift, the trust held 1,097,532 shares indirectly, while the James and Pamela Wilson Family Partners entity held 901,067 shares, and each of the 2025 Grantor Retained Annuity Trusts held 200,000 shares. Wilson has voting power under voting agreements but disclaims beneficial ownership beyond his pecuniary interest.
Insider Trade Summary
5,000 shares gifted
Gift
4 txns
Insider
WILSON JAMES N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 5,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,097,532 shares (Indirect, James N. Wilson and Pamela D. Wilson Trust);
Common Stock — 901,067 shares (Indirect, James and Pamela Wilson Family Partners);
Common Stock — 200,000 shares (Indirect, James N. Wilson 2025 Grantor Retained Annuity Trust.);
Common Stock — 200,000 shares (Indirect, Pamela D. Wilson 2025 Grantor Retained Annuity Trust.)
Footnotes (1)
- F1. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
Key Figures
Gifted shares: 5,000 shares
Trust holdings after gift: 1,097,532 shares
Family partnership holdings: 901,067 shares
+2 more
5 metrics
Gifted shares
5,000 shares
Bona fide gift on April 6, 2026
Trust holdings after gift
1,097,532 shares
James N. and Pamela D. Wilson Trust, April 6, 2026
Family partnership holdings
901,067 shares
James and Pamela Wilson Family Partners, April 6, 2026
Grantor Retained Annuity Trust holdings
200,000 shares
Each 2025 Grantor Retained Annuity Trust, April 6, 2026
Gift transaction price
$0.0000 per share
Bona fide gift, non-market transfer
Key Terms
bona fide gift, Grantor Retained Annuity Trust, beneficial ownership, voting agreements
4 terms
bona fide gift financial
"reported a bona fide gift of 5,000 shares of Common Stock"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Grantor Retained Annuity Trust financial
"each of the 2025 Grantor Retained Annuity Trusts held 200,000 shares"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
beneficial ownership financial
"disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
voting agreements financial
"has voting power over the shares held ... pursuant to voting agreements"
A voting agreement is a legally binding deal where shareholders promise to cast their votes the same way on corporate matters, such as choosing directors or approving big transactions. Think of it like a neighborhood group agreeing to support the same candidate so they can decide how the block is run; for investors, these pacts can change who controls a company, influence strategy and risk, and affect the value and liquidity of shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Corcept Therapeutics (CORT) director James N. Wilson report?
Director James N. Wilson reported a bona fide gift of 5,000 shares of Corcept Therapeutics Common Stock on April 6, 2026. The transfer was made at no price by the James N. Wilson and Pamela D. Wilson Trust and is a non-market disposition.
Does James N. Wilson claim full beneficial ownership of the reported Corcept Therapeutics (CORT) shares?
No. A footnote states that Wilson has voting power under voting agreements over shares held by the trust and family partnership but disclaims beneficial ownership, except to the extent of his pecuniary interest in those entities. This limits how much of the position is attributable to him economically.
Was the Corcept Therapeutics (CORT) insider transaction a market sale or purchase?
The filing shows a bona fide gift of 5,000 shares, not a market sale or purchase. The transaction code is G, indicating a gift transfer at a reported price per share of 0.0000, so it does not reflect an open-market trade in Corcept shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
